Thanks golf....I find it hard to believe that Apabetalone's footsteps would cause something like this....but who really knows.  

Here's a pipeline list from 2017 that lists drugs in phases 2 and 3 that target Alzheimer's.  Apabetalone isn't even on the list, which I assume is due to BETonMACE being primarily a CVD trial.  

https://www.usagainstalzheimers.org/sites/default/files/2018-01/alzheimers-drugs-development-pipeline-2017.pdf?utm_medium=PressRelease&utm_source=RA2Pipeline